UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

American Society of Clinical Oncology/College of American Pathologists 2018 Focused Update of Breast Cancer HER2 FISH Testing GuidelinesResults From a National Reference Laboratory

American journal of clinical pathology, 2019-09, Vol.152 (4), p.479-485

2019

Volltextzugriff (PDF)

RAI1 alternate probe identifies additional gastroesophageal adenocarcinoma cases as amplified following equivocal HER2 fluorescence in situ hybridization testing: experience from a national reference laboratory

Modern pathology, 2022-04, Vol.35 (4), p.549-553

2022

Volltextzugriff (PDF)

Interference of Tissue-Marking Dyes With Fluorescence In Situ Hybridization Assays

Archives of pathology & laboratory medicine (1976), 2019-11, Vol.143 (11), p.1299-1299

2019

Volltextzugriff (PDF)

Significance of GATA-3 expression in outcomes of patients with breast cancer who received systemic chemotherapy and/or hormonal therapy and clinicopathologic features of GATA-3–positive tumors

Human pathology, 2013-11, Vol.44 (11), p.2427-2431

2013

Volltextzugriff (PDF)

Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2 Fluorescent In Situ Hybridization Testing in Breast Cancers : Experience From a National Reference Laboratory

American journal of clinical pathology, 2017-10, Vol.148 (4), p.308-313

Gulbahce, H Evin

2017

Volltextzugriff (PDF)

Lobulitis in nonneoplastic breast tissue from breast cancer patients: association with phenotypes that are common in hereditary breast cancer

Human pathology, 2014, Vol.45 (1), p.78-84

2014

Volltextzugriff (PDF)

Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database

Archives of pathology & laboratory medicine (1976), 2024-03, Vol.148 (3), p.263-264

2024

Volltextzugriff (PDF)

Primary Cystic Pleuropulmonary Synovial Sarcoma Presenting as Recurrent Pneumothorax

Case reports in oncology, 2017-07, Vol.10 (2), p.660-665

2017

Volltextzugriff (PDF)

Digital imaging correlation of immunohistochemistry and fluorescence in situ hybridization in breast carcinoma cases with HER2 genetic heterogeneity

Human pathology, 2022-08, Vol.126, p.129-135

2022

Volltextzugriff (PDF)

Clinicopathologic Features of 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 Breast Carcinoma (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0)

Archives of pathology & laboratory medicine (1976), 2024-08, Vol.148 (8), p.890-897

2024

Volltextzugriff (PDF)

What to Expect From the New ASCO/CAP Guideline Recommendations for Hormone Receptor Testing in Breast Cancer: A National Reference Laboratory Experience

Applied immunohistochemistry & molecular morphology, 2021-04, Vol.29 (4), p.245-250

2021

Volltextzugriff (PDF)

Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database

American journal of clinical oncology, 2023-12, Vol.46 (12), p.559-566

2023

Volltextzugriff (PDF)

The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer: A Population-Based Study

Archives of pathology & laboratory medicine (1976), 2022-04, Vol.146 (4), p.478-484

2022

Volltextzugriff (PDF)

The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer

Archives of pathology & laboratory medicine (1976), 2022-04, Vol.146 (4), p.478-484

2022

Volltextzugriff (PDF)

Concordance between tissue microarray and whole-section estrogen receptor expression and intratumoral heterogeneity

Applied immunohistochemistry & molecular morphology, 2012-07, Vol.20 (4), p.340-343

2012

Volltextzugriff (PDF)

Differences in molecular features of triple‐negative breast cancers based on the age at diagnosis

Cancer, 2018-12, Vol.124 (24), p.4676-4684

2018

Volltextzugriff (PDF)

RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference Laboratory

Archives of pathology & laboratory medicine (1976), 2017-02, Vol.141 (2), p.274-278

2017

Volltextzugriff (PDF)

Visual Estimates of Nucleus-to-Nucleus Ratios : Can We Trust Our Eyes to Use the Bethesda ASCUS and LSIL Size Criteria?

Cancer, 2008-10, Vol.114 (5), p.287-293

2008

Volltextzugriff (PDF)

Diagnostic endoscopy in children after hematopoietic stem cell transplantation

Gastrointestinal endoscopy, 2006-09, Vol.64 (3), p.379-385

2006

Volltextzugriff (PDF)

Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer

Archives of pathology & laboratory medicine (1976), 2023-12, Vol.147 (12), p.1402-1412

2023

Volltextzugriff (PDF)

HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features

Modern pathology, 2017-11, Vol.30 (11), p.1561-1566

2017

Volltextzugriff (PDF)

Pulmonary complications after bone marrow transplantation: an autopsy study from a large transplantation center

Archives of pathology & laboratory medicine (1976), 2005-03, Vol.129 (3), p.366-371

2005

Volltextzugriff (PDF)

The FDA-Approved Breast Cancer HER2 Evaluation Kit (HercepTest; Dako) May Miss Some HER2-Positive Breast Cancers

American journal of clinical pathology, 2019-04, Vol.151 (5), p.504-510

2019

Volltextzugriff (PDF)

Histopathological Correlation of Chromosome 12 Polysomy by Fluorescence in Situ Hybridization in Adipocytic Neoplasms

International journal of surgical pathology, 2022-10, Vol.30 (7), p.734-742

2022

Volltextzugriff (PDF)

HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer

Archives of pathology & laboratory medicine (1976), 2016-08, Vol.140 (8), p.741-741

2016

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(94)
Berichte
(4)

Sprache

Englisch
(98)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

American Society of Clinical Oncology/College of American Pathologists 2018 Focused Update of Breast Cancer HER2 FISH Testing GuidelinesResults From a National Reference Laboratory

RAI1 alternate probe identifies additional gastroesophageal adenocarcinoma cases as amplified following equivocal HER2 fluorescence in situ hybridization testing: experience from a national reference laboratory

Interference of Tissue-Marking Dyes With Fluorescence In Situ Hybridization Assays

Significance of GATA-3 expression in outcomes of patients with breast cancer who received systemic chemotherapy and/or hormonal therapy and clinicopathologic features of GATA-3–positive tumors

Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2 Fluorescent In Situ Hybridization Testing in Breast Cancers : Experience From a National Reference Laboratory

Lobulitis in nonneoplastic breast tissue from breast cancer patients: association with phenotypes that are common in hereditary breast cancer

Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database

Primary Cystic Pleuropulmonary Synovial Sarcoma Presenting as Recurrent Pneumothorax

Digital imaging correlation of immunohistochemistry and fluorescence in situ hybridization in breast carcinoma cases with HER2 genetic heterogeneity

What to Expect From the New ASCO/CAP Guideline Recommendations for Hormone Receptor Testing in Breast Cancer: A National Reference Laboratory Experience

Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database

The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer: A Population-Based Study

The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer

Concordance between tissue microarray and whole-section estrogen receptor expression and intratumoral heterogeneity

Differences in molecular features of triple‐negative breast cancers based on the age at diagnosis

RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference Laboratory

Visual Estimates of Nucleus-to-Nucleus Ratios : Can We Trust Our Eyes to Use the Bethesda ASCUS and LSIL Size Criteria?

Diagnostic endoscopy in children after hematopoietic stem cell transplantation

Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer

HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features

Pulmonary complications after bone marrow transplantation: an autopsy study from a large transplantation center

The FDA-Approved Breast Cancer HER2 Evaluation Kit (HercepTest; Dako) May Miss Some HER2-Positive Breast Cancers

Histopathological Correlation of Chromosome 12 Polysomy by Fluorescence in Situ Hybridization in Adipocytic Neoplasms

HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer

Suchergebnisse filtern